Genky Drug Stores Co (TSE:9267) Cyclically Adjusted Revenue per Share: 円5,159.10 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:9267 Genky Drug Stores Co Ltd TSE:9267
82 GF Score
Price 円3,665.00
GF Value 円3,791.60
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Genky Drug Stores Co Cyclically Adjusted Revenue per Share?

Genky Drug Stores Co TSE:9267 +3.24% 82 Cyclically Adjusted Revenue per Share is 円5,159.10 as of Mar. 2026. GuruFocus rates TSE:9267 with a GF Score™ of 82/100 and a GF Value™ of 円3,791.60 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Genky Drug Stores Co's adjusted revenue per share for the three months ended in Mar. 2026 was 円1,716.600. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円5,159.10 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Genky Drug Stores Co's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Genky Drug Stores Co was 13.20% per year. The lowest was 10.30% per year. And the median was 11.90% per year.

As of today (2026-09-07), Genky Drug Stores Co's current stock price is 円3665.00. Genky Drug Stores Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was 円5,159.10. Genky Drug Stores Co's Cyclically Adjusted PS Ratio of today is 0.71.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Genky Drug Stores Co was 1.06. The lowest was 0.29. And the median was 0.68.


Genky Drug Stores Co  (TSE:9267) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Genky Drug Stores Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=3665.00/5159.10
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Genky Drug Stores Co was 1.06. The lowest was 0.29. And the median was 0.68.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Genky Drug Stores Co Cyclically Adjusted Revenue per Share Related Terms


Genky Drug Stores Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Genky Drug Stores Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genky Drug Stores Co Cyclically Adjusted Revenue per Share Chart

Genky Drug Stores Co Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,313.45 3,767.46 4,255.25 4,802.70 0.00

Genky Drug Stores Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,802.70 4,926.64 5,073.22 5,159.10 0.00

Genky Drug Stores Co Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Genky Drug Stores Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genky Drug Stores Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Genky Drug Stores Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Genky Drug Stores Co's Cyclically Adjusted PS Ratio falls into.


TSE:9267
82GF Score
Genky Drug Stores Co Ltd TSE:9267
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genky Drug Stores Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genky Drug Stores Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1716.6/112.7000*112.7000
=1,716.600

Current CPI (Mar. 2026) = 112.7000.

Genky Drug Stores Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 716.174 98.100 822.761
201609 734.156 98.000 844.279
201612 709.692 98.400 812.828
201703 707.650 98.100 812.968
201706 805.491 98.500 921.613
201709 839.819 98.800 957.972
201712 741.052 99.400 840.207
201803 733.028 99.200 832.785
201806 825.391 99.200 937.717
201809 858.353 99.900 968.332
201812 819.002 99.700 925.793
201903 790.512 99.700 893.588
201906 896.964 99.800 1,012.904
201909 939.055 100.100 1,057.258
201912 916.656 100.500 1,027.932
202003 984.104 100.300 1,105.768
202006 1,232.118 99.900 1,389.987
202009 1,154.326 99.900 1,302.228
202012 1,120.644 99.300 1,271.869
202103 1,129.732 99.900 1,274.482
202106 1,281.069 99.500 1,451.020
202109 1,287.369 100.100 1,449.415
202112 1,221.232 100.100 1,374.954
202203 1,234.578 101.100 1,376.231
202206 1,345.259 101.800 1,489.300
202209 1,402.528 103.100 1,533.122
202212 1,357.850 104.100 1,470.026
202303 1,327.202 104.400 1,432.717
202306 1,476.432 105.200 1,581.691
202309 1,542.469 106.200 1,636.876
202312 1,482.933 106.800 1,564.855
202403 1,465.883 107.200 1,541.092
202406 1,587.197 108.200 1,653.208
202409 1,644.326 108.900 1,701.704
202412 1,599.711 110.700 1,628.613
202503 1,596.933 111.100 1,619.931
202506 1,753.678 111.700 1,769.378
202509 1,837.503 112.000 1,848.987
202512 1,742.600 113.000 1,737.974
202603 1,716.600 112.700 1,716.600

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円5,159.10 mean?
Genky Drug Stores Co (TSE:9267) has a Cyclically Adjusted Revenue per Share of 円5,159.10 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Genky Drug Stores Co and its competitors.
Is Genky Drug Stores Co's Cyclically Adjusted Revenue per Share too high?
Genky Drug Stores Co's current Cyclically Adjusted Revenue per Share is 円5,159.10. Overall, Genky Drug Stores Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genky Drug Stores Co's Cyclically Adjusted Revenue per Share compare to competitors?
Genky Drug Stores Co's Cyclically Adjusted Revenue per Share of 円5,159.10 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Genky Drug Stores Co and its competitors. Genky Drug Stores Co's current Cyclically Adjusted Revenue per Share is 円5,159.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genky Drug Stores Co stock overvalued right now?
Based on GuruFocus' analysis, Genky Drug Stores Co (TSE:9267) is currently considered Fairly Valued. The stock's GF Value™ is 円3,791.60, compared to a current price of 円3,665.00 — trading 3.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円5,159.10. Genky Drug Stores Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Genky Drug Stores Co (TSE:9267), the current Cyclically Adjusted Revenue per Share is 円5,159.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genky Drug Stores Co (TSE:9267) Overvalued in 2026?

Based on GuruFocus' analysis, Genky Drug Stores Co stock appears to be undervalued. The current stock price of 円3,665.00 is trading 3.3% below its estimated GF Value™ of 円3,791.60. GuruFocus considers Genky Drug Stores Co to be Fairly Valued.

Key valuation signals for TSE:9267:

  • Cyclically Adjusted Revenue per Share: 円5,159.10
  • GF Value™: 円3,791.60 vs. price of 円3,665.00 (3.3% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the TSE:9267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genky Drug Stores Co Business Description

Address 38-33 Shimokita, Maruoka-cho, Fukui Prefecture, Sakai, JPN, 910-0332
Genky Drug Stores Co Ltd sells beauty and pharmaceutical products.
82GF Score

Get the complete analysis for TSE:9267

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,665.00
Price
円3,791.60
GF Value